Ge
No verificado

GenSight Biologics S.A.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosÓpticaSalud
08/10/2026
Mercado laboral
Industria
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Óptica
Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa
1.00
07/10/2026
Ciencia
Biotecnología
Farmacéutica
Óptica
Salud
GenSight Biologics Reports Cash Position as of September 30, 2026
1.00
29/09/2026
Mercado de valores
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Óptica
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
1.00
08/07/2026
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Óptica
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates
1.00
18/05/2026
Salud
Medicina - Varios
Farmacéutica
Óptica
Biotecnología
GenSight Biologics to Hold its Combined General Meeting on May 19, 2026
1.00
11/05/2026
Industria
Libros/Industria editorial
Biotecnología
Comunicación
Medicina - Varios
Salud
Farmacéutica
Óptica
GenSight Biologics Announces Publication on Matching-Adjusted Indirect Comparison of Leber Hereditary Optic Neuropathy Treatments
1.00
28/04/2026
Web y redes sociales
Finanzas
Salud
Biotecnología
Farmacéutica
Óptica
GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026
1.00
18/02/2026
Salud
Biotecnología
Sanidad
Medicina - Varios
Óptica
Mercado laboral
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments
1.00
10/02/2026
Biotecnología
Farmacéutica
Óptica
Sanidad
Salud
Medicina - Varios
Mercado laboral
Industria
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
1.00
28/01/2026
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Óptica
GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0